A national health ministry is establishing new regulatory standards for clinical trials. The regulations are governed by the following conditional rules:
- Any trial that tests a novel medical device must undergo a rigorous safety audit.
- A rigorous safety audit is conducted only if the trial employs an independent oversight committee.
- If a trial employs an independent oversight committee, then it must allocate five percent of its budget to patient advocacy.
- A trial cannot employ an independent oversight committee if it is exclusively sponsored by a for-profit pharmaceutical company.
- Unless a trial allocates five percent of its budget to patient advocacy, it cannot qualify for the federal innovation grant.
- All trials that are exclusively sponsored by a for-profit pharmaceutical company must undergo a commercial viability review.
Match each proposed clinical trial profile below with the deductive inference that must logically follow from the regulations.
- A trial that tests a novel medical deviceMust employ an independent oversight committee and allocate five percent of its budget to patient advocacy
- A trial exclusively sponsored by a for-profit pharmaceutical companyMust undergo a commercial viability review and cannot test a novel medical device
- A trial that qualifies for the federal innovation grant but does not employ an independent oversight committeeMust allocate five percent of its budget to patient advocacy and cannot undergo a rigorous safety audit
- A trial that fails to allocate five percent of its budget to patient advocacyCannot qualify for the federal innovation grant and cannot test a novel medical device